Umapathy's claim is that contraband detection fails on epistemology, not optics: deployed scanners match a measured spectrum against a library, so a freshly cooked explosive or a new fentanyl analogue simply is not in the book and walks through. Gyrophint trains AI on the physical and chemical properties behind the response function — the burn, the blast — so an unknown compound comes back flagged suspicious, with the family it resembles shown on the detail screen. Two patented moves make the signal good enough to bet on: mathematics that strips Rayleigh scatter and stray light out of a Raman measurement, and collecting scattered light across the full 360 degrees rather than the customary 90 or 180, which lifts signal-to-noise enough that you never have to burn a biological sample with more laser. The proof he offers is unglamorous and specific — three months at Bangalore airport on level-four checked baggage, where the instrument named thinner in a painter's unlabelled bottle and camphor in a balm in under five seconds, and where the airport wrote to the ministry for trial permission and sent its screeners into the lab to say where the buttons should go. The same physics reads body fluids, at 90 to 95 per cent accuracy on sepsis with false negatives under three per cent, but he is holding that back six to eight months to consolidate contraband first. What thirty years of citations could not buy him was capital: forty presentations across a year and a half, in a country he says has gone 75 years without a single technology it can sell to the world.
Worth your time if you are
Academics weighing whether to spin a lab out
Deep-tech founders raising a first institutional round
Aviation and border-security buyers evaluating screening tools
Diagnostics teams building models on small clinical datasets